Dengue Literature Review

DENV-2

3 min read

DENV-2

Overview

DENV-2 is one of the four dengue virus serotypes and is historically associated with the highest rates of severe dengue in secondary infections, particularly the DENV1→DENV2 sequence. The 1981 Santiago de Cuba DENV-2 epidemic was the first large DHF/DSS outbreak in the Americas and marks Cuba’s entry into the modern dengue epidemiology literature. DENV-2 has two major genotypic lineages (Asian and American) with measurably different virulence and transmissibility characteristics. It serves as the chimeric backbone for the DENVax (TAK-003) vaccine.

Key Points from Literature

  • The Asian genotype of DENV-2 replicates to higher titres in human dendritic cells, infects Ae. aegypti more efficiently, and is transmitted at higher rates than American DENV-2 strains. Amino acid changes in NS proteins appear to underlie these differences in epidemic potential (see Guzman2016 - Dengue Infection).
  • The Santiago de Cuba 1997 DENV-2 epidemic is a pivotal natural experiment: susceptible individuals (no prior dengue) developed predominantly subclinical infections; individuals with prior DENV-1 infection almost invariably developed overt disease (overt:subclinical ratio ≈ 1). The epidemic also revealed rapid within-epidemic selection: month-to-month increases in severe disease proportion and case fatality rate were observed, accompanied by a stable amino acid switch in NS1 — suggesting viral evolution during an epidemic can shift virulence (see Guzman2016 - Dengue Infection).
  • The second Cuban DENV-2 epidemic in 1981 was the first large DHF/DSS outbreak in the Americas, establishing Cuba as a key setting for dengue pathogenesis research.
  • DENV-2 serves as the attenuated PDK-53 backbone for the DENVax chimeric tetravalent vaccine candidate (TAK-003); the prM and E genes of wild-type DENV-1, -3, and -4 are substituted into the PDK-53 scaffold (see Dengue Vaccine Candidates).
  • The Cuban cohort studies (Garcia2009, Garcia2010) were conducted in individuals who had DENV-1 (1977) as their original sensitising infection and DENV-2 (1981) as a likely secondary infection before DENV-4 (2006).

CNS Tropism and Neuropathogenesis

DENV-2, along with DENV-3, is specifically implicated in direct CNS invasion causing encephalitis (rather than mere encephalopathy from systemic effects). This CNS tropism is one of three pathways to neurological disease in dengue — the others being metabolic/systemic encephalopathy and autoimmunity-mediated complications such as ADEM (see Dengue Neurological Complications). The molecular basis likely resides in NS protein variation, as genetic changes affecting NS proteins are associated with altered tissue tropism and epidemic potential across serotypes (see Shih2023 - Autoimmune Disease Risk After Dengue, Guzman2016 - Dengue Infection).

Contradictions & Debates

  • Asian genotype DENV-2 is described as more virulent than American DENV-2 — but the comparative assessment of genotype virulence is complicated by confounding factors: host immunity, mosquito vector competence, and epidemiological context (density of susceptible individuals). A direct genotypic virulence effect independent of these factors has not been cleanly demonstrated in humans.

Sources

Graph View

Backlinks